CN101057940A - 中风复元丸 - Google Patents
中风复元丸 Download PDFInfo
- Publication number
- CN101057940A CN101057940A CNA2007101060546A CN200710106054A CN101057940A CN 101057940 A CN101057940 A CN 101057940A CN A2007101060546 A CNA2007101060546 A CN A2007101060546A CN 200710106054 A CN200710106054 A CN 200710106054A CN 101057940 A CN101057940 A CN 101057940A
- Authority
- CN
- China
- Prior art keywords
- gram
- apoplexy
- radix
- patient
- grams
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000006011 Stroke Diseases 0.000 title claims abstract description 37
- 206010008190 Cerebrovascular accident Diseases 0.000 title claims abstract description 35
- 239000006187 pill Substances 0.000 title claims abstract description 19
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 16
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 16
- 241000489492 Arisaema Species 0.000 claims abstract description 13
- 210000000941 bile Anatomy 0.000 claims abstract description 13
- 241000628997 Flos Species 0.000 claims description 13
- 241000131808 Scolopendra Species 0.000 claims description 13
- 241000522620 Scorpio Species 0.000 claims description 13
- 241000255791 Bombyx Species 0.000 claims description 12
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 12
- 210000000582 semen Anatomy 0.000 claims description 12
- 239000009636 Huang Qi Substances 0.000 claims description 11
- 239000009490 scorpio Substances 0.000 claims description 11
- 241000237636 Pheretima Species 0.000 claims description 10
- 238000010298 pulverizing process Methods 0.000 claims description 2
- 241000972155 Moschus Species 0.000 claims 1
- 241000255789 Bombyx mori Species 0.000 abstract description 4
- 241000361919 Metaphire sieboldi Species 0.000 abstract description 4
- 244000020518 Carthamus tinctorius Species 0.000 abstract description 3
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract description 3
- 241000305492 Gastrodia Species 0.000 abstract description 3
- 241000173529 Aconitum napellus Species 0.000 abstract description 2
- 244000144730 Amygdalus persica Species 0.000 abstract description 2
- 241000402754 Erythranthe moschata Species 0.000 abstract description 2
- 241001481692 Mesobuthus martensii Species 0.000 abstract description 2
- 244000170916 Paeonia officinalis Species 0.000 abstract description 2
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract description 2
- 229940023019 aconite Drugs 0.000 abstract description 2
- 241000258920 Chilopoda Species 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- 229940107666 astragalus root Drugs 0.000 abstract 1
- 210000003296 saliva Anatomy 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 18
- 210000004185 liver Anatomy 0.000 description 18
- 206010010904 Convulsion Diseases 0.000 description 16
- 239000008280 blood Substances 0.000 description 16
- 210000004369 blood Anatomy 0.000 description 16
- 230000036461 convulsion Effects 0.000 description 16
- 230000036407 pain Effects 0.000 description 16
- 244000153234 Hibiscus abelmoschus Species 0.000 description 15
- 206010062717 Increased upper airway secretion Diseases 0.000 description 15
- 208000026435 phlegm Diseases 0.000 description 15
- 230000017531 blood circulation Effects 0.000 description 12
- 210000000952 spleen Anatomy 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 230000003213 activating effect Effects 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 230000007812 deficiency Effects 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 210000003414 extremity Anatomy 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 7
- 210000004072 lung Anatomy 0.000 description 7
- 230000001815 facial effect Effects 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 239000002994 raw material Substances 0.000 description 6
- 206010019233 Headaches Diseases 0.000 description 5
- 206010019468 Hemiplegia Diseases 0.000 description 5
- 210000001015 abdomen Anatomy 0.000 description 5
- 208000026106 cerebrovascular disease Diseases 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 239000003172 expectorant agent Substances 0.000 description 5
- 230000003419 expectorant effect Effects 0.000 description 5
- 231100000869 headache Toxicity 0.000 description 5
- XYKZSUXWBGUGQV-UHFFFAOYSA-N 4,8-dimethylnaphtho[2,1-f][1]benzofuran-7,11-dione Chemical compound CC1=CC=CC2=C(C(C=3OC=C(C=3C3=O)C)=O)C3=CC=C21 XYKZSUXWBGUGQV-UHFFFAOYSA-N 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 4
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 4
- -1 IIA) Chemical compound 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- AIGAZQPHXLWMOJ-UHFFFAOYSA-N Tanshinone I Chemical compound C1=CC2=C(C)C=CC=C2C(C(=O)C2=O)=C1C1=C2C(C)=CO1 AIGAZQPHXLWMOJ-UHFFFAOYSA-N 0.000 description 4
- 206010043376 Tetanus Diseases 0.000 description 4
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 4
- ZZAJQOPSWWVMBI-UHFFFAOYSA-N calycosin Chemical compound C1=C(O)C(OC)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZZAJQOPSWWVMBI-UHFFFAOYSA-N 0.000 description 4
- 206010008118 cerebral infarction Diseases 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 4
- 230000002175 menstrual effect Effects 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 206010042772 syncope Diseases 0.000 description 4
- 201000000736 Amenorrhea Diseases 0.000 description 3
- 206010001928 Amenorrhoea Diseases 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- GVKKJJOMQCNPGB-JTQLQIEISA-N Cryptotanshinone Chemical compound O=C1C(=O)C2=C3CCCC(C)(C)C3=CC=C2C2=C1[C@@H](C)CO2 GVKKJJOMQCNPGB-JTQLQIEISA-N 0.000 description 3
- GVKKJJOMQCNPGB-UHFFFAOYSA-N Cryptotanshinone Natural products O=C1C(=O)C2=C3CCCC(C)(C)C3=CC=C2C2=C1C(C)CO2 GVKKJJOMQCNPGB-UHFFFAOYSA-N 0.000 description 3
- 208000005171 Dysmenorrhea Diseases 0.000 description 3
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- PUQSUZTXKPLAPR-UJPOAAIJSA-N Gastrodin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(CO)C=C1 PUQSUZTXKPLAPR-UJPOAAIJSA-N 0.000 description 3
- 241000239226 Scorpiones Species 0.000 description 3
- 208000005392 Spasm Diseases 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 231100000540 amenorrhea Toxicity 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 210000000481 breast Anatomy 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 201000007227 lymph node tuberculosis Diseases 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 239000002304 perfume Substances 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 206010040872 skin infection Diseases 0.000 description 3
- 235000013599 spices Nutrition 0.000 description 3
- 210000001113 umbilicus Anatomy 0.000 description 3
- XUCIJNAGGSZNQT-JHSLDZJXSA-N (R)-amygdalin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O[C@@H](C#N)C=2C=CC=CC=2)O1 XUCIJNAGGSZNQT-JHSLDZJXSA-N 0.000 description 2
- PUQSUZTXKPLAPR-KSSYENDESA-N 4-(beta-D-Glucopyranosyloxy) benzyl alcohol Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1)c1ccc(CO)cc1 PUQSUZTXKPLAPR-KSSYENDESA-N 0.000 description 2
- 241001561106 Allolobophora caliginosa Species 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- LAWPHHZXTUPSDG-UHFFFAOYSA-N Astragaloside I Natural products CC(=O)OC1C(O)COC(OC2CCC34CC35CCC6(C)C(C)(CCC6(O)C7(C)CCC(O7)C(C)(C)O)C5CC(OC8OC(CO)C(O)C(O)C8O)C4C2(C)C)C1OC(=O)C LAWPHHZXTUPSDG-UHFFFAOYSA-N 0.000 description 2
- KXHCYYSIAXMSPA-UHFFFAOYSA-N Astragaloside-I Chemical compound CC(=O)OC1C(OC(=O)C)C(O)COC1OC1C(C)(C)C2C(OC3C(C(O)C(O)C(CO)O3)O)CC3C4(C)CC(O)C(C5(C)OC(CC5)C(C)(C)O)C4(C)CCC43CC42CC1 KXHCYYSIAXMSPA-UHFFFAOYSA-N 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 206010008132 Cerebral thrombosis Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 206010013952 Dysphonia Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000237858 Gastropoda Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 2
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 2
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 2
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- 241000243684 Lumbricus Species 0.000 description 2
- 229920000057 Mannan Polymers 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 208000019695 Migraine disease Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 2
- 241000282894 Sus scrofa domesticus Species 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 229960000458 allantoin Drugs 0.000 description 2
- 229940089837 amygdalin Drugs 0.000 description 2
- YZLOSXFCSIDECK-UHFFFAOYSA-N amygdalin Natural products OCC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC(C#N)c3ccccc3 YZLOSXFCSIDECK-UHFFFAOYSA-N 0.000 description 2
- 235000006533 astragalus Nutrition 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 229940107161 cholesterol Drugs 0.000 description 2
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 2
- 229960001231 choline Drugs 0.000 description 2
- 239000000812 cholinergic antagonist Substances 0.000 description 2
- 208000019902 chronic diarrheal disease Diseases 0.000 description 2
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 description 2
- HJCCJZGOBHFQSX-UHFFFAOYSA-N cyclosieversioside B Natural products CC(CCC(O)C(C)(C)OC1OC(CO)C(O)C(O)C1O)C2C(CC3(C)C4CC(O)C5C(C)(C)C(CCC56CC46CCC23C)OC7OCC(O)C(O)C7O)OC8OC(CO)C(O)C(O)C8O HJCCJZGOBHFQSX-UHFFFAOYSA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 229960003638 dopamine Drugs 0.000 description 2
- YGHHWSRCTPQFFC-UHFFFAOYSA-N eucalyptosin A Natural products OC1C(O)C(O)C(CO)OC1OC1C(OC(C#N)C=2C=CC=CC=2)OC(CO)C(O)C1O YGHHWSRCTPQFFC-UHFFFAOYSA-N 0.000 description 2
- 229930193974 gastrodin Natural products 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- PUQSUZTXKPLAPR-NZEXEKPDSA-N helicidol Natural products O([C@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](CO)O1)c1ccc(CO)cc1 PUQSUZTXKPLAPR-NZEXEKPDSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 229960001340 histamine Drugs 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 206010027599 migraine Diseases 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 210000003516 pericardium Anatomy 0.000 description 2
- 239000000467 phytic acid Substances 0.000 description 2
- 229940068041 phytic acid Drugs 0.000 description 2
- 235000002949 phytic acid Nutrition 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 244000132619 red sage Species 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 230000002048 spasmolytic effect Effects 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 210000001364 upper extremity Anatomy 0.000 description 2
- 239000002435 venom Substances 0.000 description 2
- 210000001048 venom Anatomy 0.000 description 2
- 231100000611 venom Toxicity 0.000 description 2
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 1
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 1
- URINFYYBTXOQCT-OUUBHVDSSA-N (2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-[4-[(4-hydroxyphenyl)methoxymethyl]phenoxy]oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C=C1)=CC=C1COCC1=CC=C(O)C=C1 URINFYYBTXOQCT-OUUBHVDSSA-N 0.000 description 1
- WTPPRJKFRFIQKT-UHFFFAOYSA-N 1,6-dimethyl-8,9-dihydronaphtho[1,2-g][1]benzofuran-10,11-dione;1-methyl-6-methylidene-8,9-dihydro-7h-naphtho[1,2-g][1]benzofuran-10,11-dione Chemical compound O=C1C(=O)C2=C3CCCC(=C)C3=CC=C2C2=C1C(C)=CO2.O=C1C(=O)C2=C3CCC=C(C)C3=CC=C2C2=C1C(C)=CO2 WTPPRJKFRFIQKT-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- VUIHARLRBGHPEA-UHFFFAOYSA-N 4,4,8-trimethyl-2,3,8,9-tetrahydro-1h-naphtho[2,1-f][1]benzofuran-7,11-dione Chemical compound O=C1C2=CC=C(C(CCC3)(C)C)C3=C2C(=O)C2=C1C(C)CO2 VUIHARLRBGHPEA-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- RGHHSNMVTDWUBI-UHFFFAOYSA-N 4-hydroxybenzaldehyde Chemical compound OC1=CC=C(C=O)C=C1 RGHHSNMVTDWUBI-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 241001139382 Allantion Species 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 241001614060 Amynthas aspergillus Species 0.000 description 1
- 241000213006 Angelica dahurica Species 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 241000243818 Annelida Species 0.000 description 1
- 241000169680 Aphloia theiformis Species 0.000 description 1
- 241000208340 Araliaceae Species 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 241001061264 Astragalus Species 0.000 description 1
- 235000010110 Astragalus glycyphyllos Nutrition 0.000 description 1
- 241000045403 Astragalus propinquus Species 0.000 description 1
- 241000751139 Beauveria bassiana Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- DHHFDKNIEVKVKS-FMOSSLLZSA-N Betanin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC(C[C@H]2C([O-])=O)=C1[N+]2=C\C=C\1C=C(C(O)=O)N[C@H](C(O)=O)C/1 DHHFDKNIEVKVKS-FMOSSLLZSA-N 0.000 description 1
- DHHFDKNIEVKVKS-MVUYWVKGSA-N Betanin Natural products O=C(O)[C@@H]1NC(C(=O)O)=C/C(=C\C=[N+]/2\[C@@H](C(=O)[O-])Cc3c\2cc(O)c(O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)c3)/C1 DHHFDKNIEVKVKS-MVUYWVKGSA-N 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- WLYGSPLCNKYESI-RSUQVHIMSA-N Carthamin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1[C@@]1(O)C(O)=C(C(=O)\C=C\C=2C=CC(O)=CC=2)C(=O)C(\C=C\2C([C@](O)([C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(O)=C(C(=O)\C=C\C=3C=CC(O)=CC=3)C/2=O)=O)=C1O WLYGSPLCNKYESI-RSUQVHIMSA-N 0.000 description 1
- DYQVDISPPLTLLR-HJQYTNQXSA-N Carthamin Natural products CC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)[C@]2(O)C(=C(C=C/3C(=O)C(=C(O)[C@](O)([C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C3=O)C(=O)C=Cc5ccc(O)cc5)C(=O)C(=C2O)C(=O)C=Cc6ccc(O)cc6)O DYQVDISPPLTLLR-HJQYTNQXSA-N 0.000 description 1
- 102000030523 Catechol oxidase Human genes 0.000 description 1
- 108010031396 Catechol oxidase Proteins 0.000 description 1
- 208000018152 Cerebral disease Diseases 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 241000282994 Cervidae Species 0.000 description 1
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 1
- 206010009346 Clonus Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 241001516470 Cypripedium acaule Species 0.000 description 1
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 240000001811 Dioscorea oppositifolia Species 0.000 description 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 description 1
- 241000234272 Dioscoreaceae Species 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 1
- 208000004929 Facial Paralysis Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010055690 Foetal death Diseases 0.000 description 1
- 241001312741 Gekko swinhonis Species 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019705 Hepatic pain Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- ZJJITLRIOBUSGZ-UHFFFAOYSA-N Isocryptotanshinone Natural products CC1CC2=C(O1)C(=O)c3c4CCCC(C)(C)c4ccc3C2=O ZJJITLRIOBUSGZ-UHFFFAOYSA-N 0.000 description 1
- 206010024264 Lethargy Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 241000972191 Moschus berezovskii Species 0.000 description 1
- 241000972159 Moschus chrysogaster Species 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 241000233855 Orchidaceae Species 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 244000236658 Paeonia lactiflora Species 0.000 description 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 description 1
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 241000208343 Panax Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- QFJUYMMIBFBOJY-UXZRXANASA-N Panaxatriol Chemical compound C[C@]1([C@H]2CC[C@@]3([C@@H]2[C@H](O)C[C@H]2[C@]3(C[C@@H](O)[C@H]3C(C)(C)[C@@H](O)CC[C@@]32C)C)C)CCCC(C)(C)O1 QFJUYMMIBFBOJY-UXZRXANASA-N 0.000 description 1
- VIXIMKLMEZTTTC-UHFFFAOYSA-N Panaxatriol Natural products CC1(C)CCCC(O1)C2CCC3(C)C2C(O)CC4C5(C)CCC(O)C(C)(C)C5C(O)CC34C VIXIMKLMEZTTTC-UHFFFAOYSA-N 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 244000179560 Prunella vulgaris Species 0.000 description 1
- 240000002381 Prunus davidiana Species 0.000 description 1
- 235000015533 Prunus davidiana Nutrition 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037714 Quadriplegia Diseases 0.000 description 1
- 241000218201 Ranunculaceae Species 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 description 1
- 241000316658 Sauromatum giganteum Species 0.000 description 1
- 241000131792 Scolopendridae Species 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 208000003028 Stuttering Diseases 0.000 description 1
- 208000032851 Subarachnoid Hemorrhage Diseases 0.000 description 1
- 229930183118 Tanshinone Natural products 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- 208000010798 Tongue disease Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 241000746716 Typhonium Species 0.000 description 1
- 240000000920 Typhonium flagelliforme Species 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 208000036826 VIIth nerve paralysis Diseases 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 235000012677 beetroot red Nutrition 0.000 description 1
- 239000001654 beetroot red Substances 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 235000002185 betanin Nutrition 0.000 description 1
- 235000020279 black tea Nutrition 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000003130 cardiopathic effect Effects 0.000 description 1
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical class OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000000484 citronellol Nutrition 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000002498 deadly effect Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 1
- 235000004879 dioscorea Nutrition 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930182486 flavonoid glycoside Natural products 0.000 description 1
- 150000007955 flavonoid glycosides Chemical class 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- URINFYYBTXOQCT-UHFFFAOYSA-N gastrodioside Natural products OC1C(O)C(O)C(CO)OC1OC(C=C1)=CC=C1COCC1=CC=C(O)C=C1 URINFYYBTXOQCT-UHFFFAOYSA-N 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 229930182494 ginsenoside Natural products 0.000 description 1
- 229940089161 ginsenoside Drugs 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000002008 hemorrhagic effect Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 206010019847 hepatosplenomegaly Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 231100000189 neurotoxic Toxicity 0.000 description 1
- 230000002887 neurotoxic effect Effects 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- YKRGDOXKVOZESV-UHFFFAOYSA-N paeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(CO)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-UHFFFAOYSA-N 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- AZQWKYJCGOJGHM-UHFFFAOYSA-N para-benzoquinone Natural products O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 1
- WYKQPGOKTKQHQG-UHFFFAOYSA-N parishin Natural products OC1C(O)C(O)C(CO)OC1OC(C=C1)=CC=C1COC(=O)CC(O)(C(=O)OCC=1C=CC(OC2C(C(O)C(O)C(CO)O2)O)=CC=1)CC(=O)OCC(C=C1)=CC=C1OC1C(O)C(O)C(O)C(CO)O1 WYKQPGOKTKQHQG-UHFFFAOYSA-N 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 201000001474 proteinuria Diseases 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 239000008678 sanqi Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 1
- 235000015500 sitosterol Nutrition 0.000 description 1
- 239000003998 snake venom Substances 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- WYKQPGOKTKQHQG-SHGJSZTHSA-N tris[[4-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]methyl] 2-hydroxypropane-1,2,3-tricarboxylate Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C=C1)=CC=C1COC(=O)CC(O)(C(=O)OCC=1C=CC(O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=CC=1)CC(=O)OCC(C=C1)=CC=C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 WYKQPGOKTKQHQG-SHGJSZTHSA-N 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000002255 vaccination Methods 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明涉及一种中风复元丸,它是由全蝎、蜈蚣、麝香、白僵蚕、三七、丹参、白芍、天麻、桃仁、白附子、胆南星、山药、黄芪、红花和地龙经过粉碎、混合制备而成。它属于纯中药秘方,以传统药材为原料,采用科学配比制备而成,本发明活血化淤、祛风化痰、通经活络、补益肝肾,能增强肌体免疫能力,促进肌体代谢,并有利尿,加强心肌收缩的作用。用于治疗中风、中风后遗症、猝然昏仆、不省人事、或口眼歪斜、语言不利、半身不遂,对于脑血栓、脑梗塞、脑出血后遗症等患者具有满意疗效。它纯天然,无毒副作用而且组方简单,成本低廉。
Description
技术领域
本发明涉及一种中风复元丸,具体的说是涉及一种以中草药为原料的活血化淤、祛风化痰、通经活络的广泛用于各种中风、中风后遗症的药物。
技术背景
中风,西医称为急性脑血管病或脑卒中,具有发病率高、死亡率高、致残率高、复发率高以及并发症多的“四高一多”特点。主要分为出血性脑中风(脑出血或蛛网膜下腔出血)和缺血性脑中风(脑梗塞、脑血栓形成)二大类,以脑梗塞最为常见。近年多次流行病学调查结果表明中风的患病率国外为150~250/10万,我国为97~144/10万,老年人发病为5%。中风发病急,病势凶险,国内住院病人的病死率高达64~78%,每年死于中风者近100万人,居各病之首。中风的死亡率有随年龄增长而上升的趋势,世界卫生组织(WHO)发表的1997年“世界健康状况”报告已把它列为仅次于心脏病的世界第二位的致死疾病。中医历来称它为“四大难症”之首。如果能较顺利地度过死亡这一关,约有59%左右遗留半身不遂或说话不利落等后遗症。1987年中华人民共和国国家统计局关于全国残疾人抽样调查主要数据的公报中指出:脑内疾病所引起的肢体残疾约118人,占全部肢体残疾者的15.63%,我国幸存者中约3/4不同程度丧失劳动力,重度致残者占40%以上。实际上,中风病后遗症已成为国际医学界康复治疗的难题。由于一直缺乏有效的治疗措施,所以,如何提高中风病的康复疗效,一直是医务工作者和社会工作者极为关注的问题。但是,迄今为止,中风及其后遗症尚无特殊的药物治疗。
发明内容
本发明的目的在于提供一种以中国传统中药为原料,无毒副作用,疗效突出的,具有活血化淤、祛风化痰、通经活络、补益肝肾功效、适用于中风、中风后遗症、猝然昏仆、不省人事、或口眼歪斜、语言不利、半身不遂的中风复元丸。
本发明的目的是这样实现的:它是由全蝎1-3个、蜈蚣1-3条、麝香1-3克、白僵蚕1-3克、三七1-3克、丹参2-4克、白芍2-4克、天麻1-3克、桃仁1-3克、白附子4-8克、胆南星4-7克、山药2-4克、黄芪3-5克、红花1-3克和地龙1-3克配比,经过粉碎、混合制备而成的中风复元丸。
其中,全蝎,Scorpio,又名全虫、蝎子,(英)Scorpion,为钳蝎科动物东亚钳蝎Buthus martensii Karsch的干燥体。含蜗毒(Katsutoxin),系一种类蛇毒样神经毒的蛋白质。此外,并含蝎酸、三甲胺、甜菜碱、牛磺酸、软脂酸、硬脂酸、胆舀酵、卵磷脂及铵盐等。性平,味辛。归肝经。可息风镇痉,攻毒散结,通络止痛。用于小儿惊风,抽搐痉挛,中风口蜗,半身不遂,破伤风,风湿顽痹,偏正头痛,疮疡,瘰疬。
蜈蚣,Scolopendra,又名百足虫、金头蜈蚣,(英)Scorpion,为蜈蚣科动物少棘巨蜈蚣Scolopendra subspinipesmu-tilans L.Koch的全体。含二种类似蜂毒的有毒成分,即组织胺(Histamine)样物质及溶血蛋白质;此外尚含酪氨酸(Tyrosine)、亮氨酸(Leucine)、蚁酸、脂肪油、胆固醇等。性温,味辛。有毒。归肝经。可祛风,镇痉,解毒。用于惊痫抽搐、痉挛、破伤风、肿毒瘰症,蛇咬伤等症。
麝香,Moschus,又名当门子、脐香、麝脐香、四味臭、臭子、腊子、香脐子,(英)Musk。为鹿科动物原麝林麝Moschusberezovskii Flerov或马麝Moschus sifanicus przewalskii成熟雄性腹部香囊中的分泌物。味辛,性温。归心、脾经。具有开窍醒神,活血散瘀,止痛,催产功能。用于温热病热入心包神昏痉厥,中风痰厥、惊痫等闭证。内服或外用于疮疡肿毒。用于心腹暴痛、跌打损伤及痹证诸痛。用于胎死腹中或胞衣不下等证。
僵蚕,Bombyx Batryticatus,又名姜虫、白僵蚕,(英)White silkworm,为蚕娥科昆虫家蚕Bombyx mori Linnaeus.4~5龄的幼虫感染(或人工接种)白僵菌Beauveria bassiana(Bals.)Vuillant而致死的干燥体。性平,味咸、辛。归肝、肺、胃经。可祛风定惊,化痰散结。用于惊风抽搐,咽喉肿痛,皮肤瘙痒,颌下淋巴结炎,面神经麻痹。
三七,Radix Notoginseng,又名金不换,田三七、三七、参三七、盘龙七、狗头三七,(英)Sanqi,为五加科植物三七Panaxnotoginseng(Burk.)F.H.Chen的干燥根。含总皂甙约12%,经薄层鉴定,和人参所含皂甙类似,主要为人参皂甙Rb1,Re1,Rg1。三七总皂甙水解后,主要得人参三醇,其次为人参二醇,未检出齐墩果酸。此外,尚含黄酮甙、淀粉、蛋白质、油脂、并有生物碱反应。性温,味辛。归肝、胃经。具有散瘀止血、消肿定痛之功能。用于咯血、吐血、衄血、便血、崩漏、外伤出血、胸腹刺痛、跌扑肿痛。
丹参,Radix Salviae Miltiorrhizae,(英)Danshen Root,为唇形科植物丹参Salvia miltiorrhiza Bge.根及根茎。植物形态多年生草本。含丹参酮I、IIA、IIB(tanshinone I、IIA、IIB)异丹参酮I、IIA(isotanshinone I、IIA)、隐丹参酮(cryptotanshinone)、异隐丹参酮(isocryptotanshin-one)、甲基丹参酮(methyItanshinone)、羟基丹参酮等。性微寒,味苦。归心、心包、肝经。具有祛瘀止痛,活血通经,清心除烦功能。用于月经不调、经闭痛经、症瘕积聚、胸腹刺痛、热痹疼痛、疮疡肿痛、肝脾肿大、心绞痛。
白芍,Radix Paeoniae Alba,又名白芍药、离草,(英)White Paeony Root,为毛茛科植物芍药Paeonia lactiflora Pall.的干燥根。含芍药甙、挥发油、苯甲酸、鞣质及B一谷甾醇等。性微寒,味苦、酸。归肝、脾经。可平肝止痛,养血调经,敛阴止汗。用于头痛眩晕,胁痛,腹痛,四肢挛痛,血虚萎黄,月经不调,自汗,盗汗。
天麻,Rhizoma Gastrodiae,又名鬼督邮、水洋芋、赤箭,(英)Tall Gastrodia Tuber,为兰科植物天麻Gastrodia elataBl.的干燥块茎。含天麻甙(gastrodin)、天麻甙元、天麻醚甙(gastrodioside)、派立辛(parishin)、香草醇、β-甾醇、对羟基苯甲醛、柠檬酸、琥珀酸等。性平,味甘。归肝经。可平肝息风止痉。用于头痛眩晕,肢体麻木,小儿惊风,癫痫抽搐,破伤风。
桃仁,Semen Persicae,又名毛桃仁、扁桃仁、大桃仁,(英)Peach Seed,为蔷薇科植物桃Prunus persica(L.)Batsch或山桃Prunus davidiana(Carr.)Franch.的干燥成熟种子。含苦杏仁甙(amygdalin)、苦杏仁酶(emulsin)、脂肪油等。性平,味苦、甘。归心、肝、大肠经。可活血祛痰,润肠通便。用于经闭、痛经、症瘕痞块、跌扑损伤、肠燥便秘。
关白附,Radix Aconiti Coreani,又名白附子,(英)aconite typhonium,为天南星科植物独角莲Typhoniumgiganteum Engl.的块茎。味辛,性温;有毒。归胃、肝经。具有祛风痰,定惊搐,解毒散结止痛功能。用于中风痰壅,口眼歪斜,语言涩謇,痰厥头痛,偏正头痛,喉痹咽痛,破伤风症;外治瘰疬痰核,毒蛇咬伤。
胆南星,Arisaema Cum Bile,又名胆星,(英)ArisaemawithBile,为制天南星的细粉与牛、羊或猪胆汁加工而成,或为生天南星细粉与牛、羊或猪胆汁经发酵加工而成。味苦、微辛,性凉。归肺、肝、脾经。具有清热化痰,息风定惊功能。用于痰热咳嗽,咯痰黄稠,中风痰迷,癫狂惊痈。
山药,Rhizoma Dioscoreae,又名淮山药、怀山药、山菇,(英)Common Yam Rhizome,为薯蓣科植物薯蓣Dioscoreaopposita Thunb.的根茎。含甘露聚糖(mannan)、3,4-二羟基苯乙胺、植酸(phytic acid)、尿囊素(allantion)、胆碱、多巴胺(dopamine)、山药碱(batatasine),以及10余种氨基酸、糖蛋白、多酚氧化酶。性平,味甘。归脾、肺、肾经。具有补脾养胃,生津益肺,补肾涩精功能。用于脾虚食少、久泻不止、肺虚喘咳、肾虚遗精、带下、尿频、虚热消渴。
黄芪,Radix Astragali,(英)Milkvetch Root,为豆科植物蒙古黄芪Astragalus membranaceus Bge.var.mongholicus(Bge.)Hsiao的根。含黄酮类成分毛蕊异黄酮(calycosin)、3-羟基-9,10-二甲氧基紫檀烷,还含黄芪皂甙I、V、III(astragaloside I、V、III)。性温,味甘。归脾、肺经。具有补气固表,托毒排脓,利尿,生肌功能。用于气虚乏力、久泻脱肛、自汗、水肿、子官脱垂、慢性肾炎蛋白尿、糖尿病、疮口久不愈合。
红花,Flos Carthami,又名红蓝花、刺红花,(英)Safflower,为植物菊科红花Carthamus tinctorius L.的花。含红花甙、红茶醌甙及药花油等。性温,味辛。归心、肝、脾经。可活血通经,散瘀止痛。用于经闭,痛经,恶露不行,癥瘕痞块,跌扑损伤,疮疡肿痛。
地龙,Lumbricus,又名蚯蚓干、曲蟮,(英)earthworm,为环节动物门钜蚓科动物Pheretima aspergillum(Perrier)或缟蚯蚓Allolobophora caliginosa(Savigny)trapezoides(Ant.Dugés)的干燥体。含有蚯蚓素,蚯蚓解热碱,以及脂肪酸、类脂化合物、胆固醇、胆碱、维生素B、黄尿圜、胍及磷等。性寒,味咸。归肝、脾、膀胱经。清热定惊,通络,平喘,利尿。用于高热神昏,惊痫抽搐,关节痹痛,肢体麻木,半身不遂,肺热喘咳,尿少水肿;高血压。
本发明与现有技术相比,它属于纯中药秘方,以传统药材为原料,采用科学配比制备而成,蝎子蜈蚣配伍息内风、祛风、止痉抽、通络止痛;地龙清热息风、通络、利尿;麝香辛香走窜、开窍、活血通经;三七化淤、活血定痛;白附子燥湿化痰、祛风止痉;白僵蚕息风止痉、祛风止痛、解毒散结化痰;天麻息风止痉、平肝潜阳;白芍养血敛阴、平抑肝阳、柔肝止痛;丹参活血祛痰、凉血消痛、养血安神;当归养血补虚、活血止痛、润肠通便;桃仁活血祛淤、润肠痛便;红花活血祛淤、通经;山药补脾肺肾、益气养阴;黄芪补气。本发明活血化淤、祛风化痰、通经活络、补益肝肾,能增强肌体免疫能力,促进肌体代谢,并有利尿,加强心肌收缩的作用。它针对中风风旋动、夹痰夹火、淤阻脉络、蒙蔽心窍、风火交煽、痰浊壅塞、淤血内阻为标,本虚标实或上盛下虚的症候,全方共奏活血化淤,化淤通络、补益肝肾、标本兼治以达到治疗中风、中风后遗症、猝然昏仆、不省人事、或口眼歪斜、语言不利、半身不遂功效,对于脑血栓、脑梗塞、脑出血后遗症等患者具有满意疗效。它纯天然,无毒副作用而且组方简单,成本低廉。
具体实施方式
以下结合实施例进一步说明本发明
实施例1
分别选取符合《中华人民共和国药典》规定的全蝎、蜈蚣、麝香、白僵蚕、三七、丹参、白芍、天麻、桃仁、白附子、胆南星、山药、黄芪、红花和地龙为原料,去杂除尘。清洗后秤取全蝎1个、蜈蚣3条、麝香1克、白僵蚕3克、三七1克、丹参4克、白芍2克、天麻3克、桃仁1克、白附子8克、胆南星4克、山药4克、黄芪3克、红花3克和地龙1克,粉碎混合,制成丸剂,即得一种中风复元丸。
实施例2
分别选取符合《中华人民共和国药典》规定的全蝎、蜈蚣、麝香、白僵蚕、三七、丹参、白芍、天麻、桃仁、白附子、胆南星、山药、黄芪、红花和地龙为原料,去杂除尘。清洗后秤取全蝎3个、蜈蚣1条、麝香3克、白僵蚕1克、三七3克、丹参2克、白芍4克、天麻1克、桃仁3克、白附子4克、胆南星7克、山药2克、黄芪5克、红花1克和地龙3克,粉碎混合,制成丸剂,即得一种中风复元丸。
实施例3
分别选取符合《中华人民共和国药典》规定的全蝎、蜈蚣、麝香、白僵蚕、三七、丹参、白芍、天麻、桃仁、白附子、胆南星、山药、黄芪、红花和地龙为原料,去杂除尘。清洗后秤取全蝎2个、蜈蚣2条、麝香2克、白僵蚕2克、三七2克、丹参3克、白芍3克、天麻2克、桃仁2克、白附子6克、胆南星5克、山药3克、黄芪4克、红花2克和地龙2克,粉碎混合,制成丸剂,即得一种中风复元丸。
实施例4
曹XX,性别:女,年龄:48岁,主诉:患者素有高血压病史三年,间断服用罗布麻和其他的降压药物,4天前晚上突然出现昏迷状态,片刻头疼眩晕,左侧肢体麻木无力,发软,症见脉细弱、面色苍白、气急、舌尖红、苔微黄、左上下肢已经失去知觉,针刺无痛感觉、口眼歪斜、大便微干、小便黄色。诊断中风偏瘫。予以中风复元丸15日后拄拐杖在屋内行走,继续服药,二月后患者诸症状恢复,活动如常人,随访至今未复发。
实施例5
刘XX,性别:女,年龄:56岁,主诉:患者素有喘咳5年有余、水肿三年余、血压正常一日做饭跌到,先到林业局医院治疗半月无效,患者面赤水肿、喘咳、喉中有痰鸣声、舌苔白、坐上下肢失去知觉、针刺无痛感、头痛、晕胀、喘咳、脉沉细迟、诊断为风痰偏瘫,上壅清窍、痰湿内生、痰浊壅滞,予以中风复元丸治疗一周后可以在屋内行走,一个月后诸症基本消失。共服药二个月,已几年未见复发。
实施例6
田XX,性别:男,年龄:58岁,主诉:患者与邻居老人打牌突然跌倒在地,口吐白沫。当即送医救治,时间达一个月之久,仍不能独立下床行走,后来我处视诊,四肢麻痹无力,走路困难,述3-4天大便未行、口常吐白粘痰、平时好白酒、嗜睡、头晕、头重脚轻、食纳不佳、脉强数滑、舌淡、苔白腻予以中风复元丸20日后大小便通畅,白痰亦大减、手足麻痹减、但仍无力、脉细弦而数、舌淡、苔薄黄略腻、续服二个月后个症状均愈。
实施例7
周XX,性别:男,年龄:70岁,主诉:患者早起突感头晕,单侧上下肢麻木无力、口眼歪斜、舌僵语塞、曾在林业医院住一个月院仍然是一侧偏废无用,来我处予以中风复元丸连服20日后语言清晰流利,上下肢活动自如,行走将近正常,继服一月,一切自理,至今未复发。
实施例8
白XX,性别:男,年龄:56岁,主诉:患者面色暗淡、舌绛苔厚、易昏睡、患肢热甚、脉弱有力、口眼歪斜、喉中痰鸣、四肢软瘫、予以中风复元丸半月,患者神志恢复,四肢均无力瘫软,继用一月后、患者五官端正、语言清晰、已能下地行走,续用一月至今未见复发
实施例9
颜XX,性别:男,年龄:50岁,主诉:患者嗜好烟酒,有高血压已经三年时轻时重,因为突然昏倒送医救治,诊断为多发性脑梗塞,予以中风复元丸治疗6天后神志转清,病情好转。服药一月后病情进一步好转,病手已经能持物,共服二月后,生活已经能自理,至今未复发。
实施例10
杨XX,性别:男,年龄:54岁,主诉:平素血压偏高,因为突然昏倒送医救治,治疗半月后仍口眼歪斜、语言塞涩、来我处就诊,予以中风复元丸服用二周后、口歪转正、言语清朗、四肢除右上肢仍麻痹不举、握物无力外、其余活动自如,继服45天后,身体恢复正常,能干农活。至今未见复发。
实施例11
华XX,性别:男,年龄:49岁,主诉:患者突发左侧偏瘫,语言不清,口眼歪斜,既往有高血压病史就医诊断为左侧偏瘫遂投以中风复元丸,四日后神志清晰,又服30日左侧肢体活动度增加,又服用二个月,生活能自理,半年后即恢复劳动。
实施例12
王XX,性别:男,年龄:46岁,主诉:患者经市医院救治呈半昏迷状态,口眼歪斜,四肢不温,左半身瘫痪,临床诊断为脑梗塞,邀余诊治,诊其脉细而弦,舌淡苔黄,遂予以中风复元丸灌服次日下午神志转清醒,有饥饿感继服20日,其患基本恢复,行动仅存在左半身不适之感,嘱其服一月以资巩固。
实施例13
赵XX,性别:男,年龄:58岁,主诉:患者回家突感左半身麻木,活动不灵,口眼歪斜,语言吐字不清来我出就诊,舌大暗,苔薄白,脉沉细予以中风复元丸5日后麻木感减轻,左下肢稍能活动,继续用药20日后,病人语言清晰,左上下肢活动基本恢复正常,继用半月以巩固疗效至今未复发。
实施例14
藤XX,性别:男,年龄:50岁,主诉:患者在牡丹市二院诊治,临床诊断为脑血栓形成,住院半月,疗效不显著,来我处就诊,其症胸闷,心烦咽干,思饮、小便色深,脉弦细而数、舌质红、苔薄少津。投以中风复元丸连服3日烦热退,语言转清,口鼻歪斜见减,连服一月诸症状皆减,康复如常,至今未见复发。
实施例15
窦XX,性别:女,年龄:50岁,主诉:患者经常头晕,肢体麻木,头痛到医院做CT检查为脑梗塞,患者身体肥胖,神志清楚,左侧肢体麻木,感觉障碍活动不灵,舌尖赤、苔黄腻、脉弦滑,投以中风复元丸2周后头痛减轻,咀嚼较好,肢体麻木减轻,继续服一月颜面感觉功能恢复,语言基本流畅,又服半月,至今恢复正常,未复发。
实施例16
王XX,性别:男,年龄:54岁,主诉:患者在医院治疗一月出院,生活不能自理,半身不遂,口眼歪斜,言语塞涩,带有痰声不能起床,脉沉而细,右侧肢体偏瘫,小便失禁后来我处就诊,予以中风复元丸治疗一月,能起床走路,服用四月后身体基本恢复正常,生活能自理,至今未见复发。
实施例17
龚XX,性别:男,年龄:52岁,主诉:患者患病左侧肢体偏瘫,语言不清,口角右面色无华、舌体左斜、舌苔薄白、脉沉弦今予以中风复元丸服用5天后左上肢能上举齐眉,继服45天后,五官正、语言清晰、左侧肢体恢复,生活基本能自理,继服药一月以巩固疗效,共服用三个月痊愈,至今健康。
实施例18
姜XX,性别:男,年龄:54岁,主诉:患者主诉突发右侧肢体偏瘫、鼻唇沟变浅,舌体向右侧歪斜,在牡丹江市红旗医院住院半月,现仍左侧上肢肌肉松弛,不能自主屈伸,语言塞涩,舌暗红,苔薄白,脉弦细等,检查诊断为脑出血后遗症,予以中风复元丸治疗,服药4天后,患者右上肢就可以屈伸了,服用20日后患者语言稍清,继服一月后,患者五官正,语言清,肢体活动自如,共服药三个月至今未复发。
实施例19
刘XX,性别:女,年龄:58岁,主诉:患者主诉右边半身麻木不仁,走路艰难,口眼歪斜,语言不清楚带有痰声,不能起来,脉沉弦投以中风复元丸治疗,20日后患者侧觉温,口歪渐轻,语言仍有不清,又服20天,已能起床行走,语言亦见清晰,五官端正,继服一月以资巩固,至今未发。
实施例20
丁XX,性别:女,年龄:60岁,主诉:患者自觉头昏头痛,耳鸣眼花,继而出现口眼歪斜,舌僵,左上肢失去知觉,遂来我处,查舌质红,苔黄腻,送往医院做CT检查为脑梗塞,因不愿住院,余给投以中风复元丸治疗,七日复诊患者诸症好转,惟头昏较甚,肢体活动受限,继服25日患者口眼歪斜消失,语言清楚,唯左下肢活动稍受限,嘱继服药二月患者活动自如,今已康复,未见复发。
实施例21
徐XX,性别:女,年龄:58岁,主诉:患者口眼歪斜,语言不利,口角流涎,双下肢瘫痪,来我处就疹,查患者除前述症状外,兼体倦无力,舌淡紫,有淤斑,脉细涩,予以中风复元丸10日后语言不利,口角流涎消除,口眼歪斜基本恢复,双下肢有瘫痪转为麻木,可搀扶行走,患者共服二个月药后下肢活动自如康复,至今无复发。
实施例22
宋XX,性别:女,年龄:58岁,主诉:患者左侧肢体瘫痪,疲倦无力,神志清楚,无大小便失禁,无高血压,体温正常,精神尚可,面容端正,被动体味,能正确对答,个别字语不清楚,舌质暗淡,苔薄白,脉沉细无力,左侧肢体瘫痪,半身麻木,皮肤温度底于健侧,痛觉消失,给予中风复元丸治疗,14日后病人肢体麻木减轻,稍能活动,脉细稍有力,有服用10日后病之上肢可抬举过头,手能握持,但无力,下肢可在搀扶下行走,病人又连服30余日,左上肢已活动自如,手握持有力,穿衣解扣如常人,下肢活动基本恢复正常。继服半月,并嘱其加强功能锻炼,注意生活调理,病获痊愈,随访未见复发。
实施例23
于XX,性别:女,年龄:40岁,主诉:患者右侧颜面麻木,口眼歪斜,右半身活动受限,步伐迟缓,语言略有涩,到医院做CT诊断为脑梗塞,余诊其脉沉弦,舌淡苔白微腻,予以中风复元丸,30日后,病者颜面自觉舒适,语言流利,但口眼开合还不自如,步伐欠灵活,继续服药一月诸症悉除,随访至今未复发。
实施例24
临床总结
总结对象:100人,年龄40-70岁,其中女性40人,男性60人。
临床方法:口服本发明的中风复元丸。使用时伴饭吃下,一次一丸,一日两次。
疗效评价:
临床(例) | 无效(例) | 放弃(例) | 有效(例) | 痊愈(例) | 有效率(%) | 痊愈率(%) | 疗程(月) | |
女性 | 40 | 1 | 1 | 38 | 33 | 94 | 76 | 1-6 |
男性 | 60 | 2 | 2 | 56 | 43 |
Claims (1)
1、一种中风复元丸,它是由全蝎1-3个、蜈蚣1-3条、麝香1-3克、白僵蚕1-3克、三七1-3克、丹参2-4克、白芍2-4克、天麻1-3克、桃仁1-3克、白附子4-8克、胆南星4-7克、山药2-4克、黄芪3-5克、红花1-3克和地龙1-3克配比,经过粉碎、混合制备而成的中风复元丸。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA2007101060546A CN101057940A (zh) | 2007-05-31 | 2007-05-31 | 中风复元丸 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA2007101060546A CN101057940A (zh) | 2007-05-31 | 2007-05-31 | 中风复元丸 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101057940A true CN101057940A (zh) | 2007-10-24 |
Family
ID=38864343
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2007101060546A Pending CN101057940A (zh) | 2007-05-31 | 2007-05-31 | 中风复元丸 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101057940A (zh) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102988645A (zh) * | 2012-10-23 | 2013-03-27 | 潘根起 | 一种治疗面神经麻痹的中药组合物及制备方法 |
CN103393878A (zh) * | 2013-07-22 | 2013-11-20 | 福建锡安贸易有限公司 | 一种治疗脑中风偏瘫的中药及其制备方法 |
CN103495001A (zh) * | 2013-09-29 | 2014-01-08 | 谭崇展 | 一种用于治疗眩晕、中风、痴呆病的中药组合物 |
CN105287724A (zh) * | 2014-06-15 | 2016-02-03 | 张红伶 | 一种治疗面神经麻痹的药物 |
CN105362740A (zh) * | 2015-11-16 | 2016-03-02 | 宁国仙霞骨伤医院 | 一种用于治疗中风的中药组合物及其应用 |
CN105770487A (zh) * | 2016-01-11 | 2016-07-20 | 陕西理工学院 | 一种治疗脑梗塞脑出血后遗症的中药组合物及其制备方法 |
CN106880727A (zh) * | 2017-04-06 | 2017-06-23 | 李少伦 | 一种治疗中风后遗症的药物及其制备方法 |
-
2007
- 2007-05-31 CN CNA2007101060546A patent/CN101057940A/zh active Pending
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102988645A (zh) * | 2012-10-23 | 2013-03-27 | 潘根起 | 一种治疗面神经麻痹的中药组合物及制备方法 |
CN103393878A (zh) * | 2013-07-22 | 2013-11-20 | 福建锡安贸易有限公司 | 一种治疗脑中风偏瘫的中药及其制备方法 |
CN103393878B (zh) * | 2013-07-22 | 2015-08-05 | 福建锡安贸易有限公司 | 一种治疗脑中风偏瘫的中药及其制备方法 |
CN103495001A (zh) * | 2013-09-29 | 2014-01-08 | 谭崇展 | 一种用于治疗眩晕、中风、痴呆病的中药组合物 |
CN105287724A (zh) * | 2014-06-15 | 2016-02-03 | 张红伶 | 一种治疗面神经麻痹的药物 |
CN105362740A (zh) * | 2015-11-16 | 2016-03-02 | 宁国仙霞骨伤医院 | 一种用于治疗中风的中药组合物及其应用 |
CN105770487A (zh) * | 2016-01-11 | 2016-07-20 | 陕西理工学院 | 一种治疗脑梗塞脑出血后遗症的中药组合物及其制备方法 |
CN106880727A (zh) * | 2017-04-06 | 2017-06-23 | 李少伦 | 一种治疗中风后遗症的药物及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100551422C (zh) | 一种治疗椎间盘突出的内服药物 | |
CN1325083C (zh) | 一种用于除湿止痒的药物组合物及其制备方法和用途 | |
CN102178800B (zh) | 一种治疗类风湿性关节炎的中药组合物及其制备方法 | |
CN1190217C (zh) | 一种治疗皮肤病的药物 | |
CN101057940A (zh) | 中风复元丸 | |
CN101185673B (zh) | 一种治疗鼻窦炎的药物 | |
CN101972386A (zh) | 一种治疗糖尿病痛风的中药 | |
CN100586458C (zh) | 治疗脑中风病药物 | |
CN102423423B (zh) | 一种治疗尿路感染的中药 | |
CN104225221B (zh) | 一种治疗糖尿病周围性神经病变的中药 | |
CN103285284B (zh) | 一种治疗老年性阴道炎的药物组合物 | |
CN103191399A (zh) | 用于治疗支气管哮喘急性发作期的中药组合物 | |
CN102579818A (zh) | 一种藏药组合物及其制备方法与应用 | |
CN104622995A (zh) | 一种治疗慢性浅表性胃炎的药物组合物及其制备方法 | |
CN116492412B (zh) | 一种治疗血虚络阻证末梢神经炎的中药组合物 | |
CN1876088A (zh) | 一种治疗慢性前列腺炎的药物及其制备方法 | |
CN104758733A (zh) | 一种治疗老年性阴道炎的外洗剂 | |
CN117959394B (zh) | 参芪通脉制剂在制备防治糖尿病神经病变药物中的用途 | |
CN1876015A (zh) | 一种治疗风湿的药物 | |
CN102370916A (zh) | 一种治疗急性肾小球肾炎的中药 | |
CN102671052B (zh) | 治疗美尼尔氏综合症的中药组合物 | |
CN101961459B (zh) | 一种治疗偏枯的内服药物 | |
CN1299748C (zh) | 一种减肥调理补气袋 | |
CN101954018A (zh) | 一种治疗慢性肾炎的内服药物 | |
CN1927349A (zh) | 一种治疗痹症的中药及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C57 | Notification of unclear or unknown address | ||
DD01 | Delivery of document by public notice |
Addressee: Xu Mingbo Document name: Written notice of preliminary examination of application for patent for invention |
|
C06 | Publication | ||
PB01 | Publication | ||
DD01 | Delivery of document by public notice |
Addressee: Xu Mingbo Document name: Notification of before Expiration of Request of Examination as to Substance |
|
DD01 | Delivery of document by public notice |
Addressee: Xu Mingbo Document name: Notification that Application Deemed to be Withdrawn |
|
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20071024 |